HealthSouth Corp. (HLS) Receives $46.50 Average PT from Brokerages
HealthSouth Corp. (NYSE:HLS) has been assigned a consensus rating of “Buy” from the ten brokerages that are covering the company. One investment analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and seven have given a buy recommendation to the company. The average 12 month price target among brokerages that have covered the stock in the last year is $46.80.
HLS has been the subject of several analyst reports. Wells Fargo & Co. reissued a “buy” rating on shares of HealthSouth Corp. in a research report on Sunday, September 11th. Royal Bank Of Canada raised their price target on shares of HealthSouth Corp. from $46.00 to $48.00 and gave the company an “outperform” rating in a research report on Monday, October 31st. Zacks Investment Research raised shares of HealthSouth Corp. from a “hold” rating to a “buy” rating and set a $45.00 price target for the company in a research report on Monday, October 31st. RBC Capital Markets reissued an “outperform” rating and set a $48.00 price target (up previously from $46.00) on shares of HealthSouth Corp. in a research report on Monday, October 31st. Finally, SunTrust Banks Inc. set a $54.00 price target on shares of HealthSouth Corp. and gave the company a “buy” rating in a research report on Monday, August 1st.
Shares of HealthSouth Corp. (NYSE:HLS) opened at 40.97 on Tuesday. The company has a market cap of $3.68 billion, a P/E ratio of 17.08 and a beta of 0.90. HealthSouth Corp. has a 12-month low of $30.26 and a 12-month high of $43.38. The company has a 50-day moving average price of $40.19 and a 200-day moving average price of $40.45.
HealthSouth Corp. (NYSE:HLS) last announced its earnings results on Thursday, October 27th. The company reported $0.65 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.60 by $0.05. HealthSouth Corp. had a net margin of 6.31% and a return on equity of 29.27%. The business earned $926.80 million during the quarter, compared to the consensus estimate of $448.60 million. During the same quarter last year, the firm earned $0.52 earnings per share. The business’s revenue for the quarter was up 19.0% on a year-over-year basis. On average, analysts predict that HealthSouth Corp. will post $2.55 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, January 17th. Stockholders of record on Tuesday, January 3rd will be paid a dividend of $0.24 per share. This represents a $0.96 annualized dividend and a dividend yield of 2.34%. The ex-dividend date of this dividend is Thursday, December 29th. HealthSouth Corp.’s dividend payout ratio is presently 40.17%.
In other HealthSouth Corp. news, CFO Douglas E. Coltharp purchased 6,450 shares of the company’s stock in a transaction dated Wednesday, November 9th. The shares were acquired at an average price of $39.14 per share, for a total transaction of $252,453.00. Following the purchase, the chief financial officer now directly owns 104,637 shares of the company’s stock, valued at approximately $4,095,492.18. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, COO Mark J. Tarr purchased 6,371 shares of the company’s stock in a transaction dated Wednesday, November 9th. The shares were acquired at an average price of $39.29 per share, for a total transaction of $250,316.59. Following the purchase, the chief operating officer now directly owns 238,890 shares in the company, valued at $9,385,988.10. The disclosure for this purchase can be found here. Insiders own 5.00% of the company’s stock.
Several hedge funds and other institutional investors have recently modified their holdings of the company. Piedmont Investment Advisors LLC acquired a new position in shares of HealthSouth Corp. during the third quarter valued at $513,000. Crow Point Partners LLC acquired a new position in shares of HealthSouth Corp. during the third quarter valued at $189,000. Kalos Management Inc. boosted its position in shares of HealthSouth Corp. by 14.4% in the third quarter. Kalos Management Inc. now owns 42,494 shares of the company’s stock valued at $1,724,000 after buying an additional 5,338 shares in the last quarter. Verition Fund Management LLC acquired a new position in shares of HealthSouth Corp. during the third quarter valued at $648,000. Finally, Boston Private Wealth LLC acquired a new position in shares of HealthSouth Corp. during the third quarter valued at $498,000. Institutional investors and hedge funds own 96.10% of the company’s stock.
HealthSouth Corp. Company Profile
HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in over 30 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company’s segments include inpatient rehabilitation, and home health and hospice.
Receive News & Stock Ratings for HealthSouth Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth Corp. and related stocks with our FREE daily email newsletter.